StudyManager Unveils Reveal Version 3.3
StudyManager
announced the release of
Reveal 3.3
, with enhanced features that provide greater ease of use and performance for research sites, academic medical centers, and hospitals.
Based on customer feedback and StudyManager’s nearly 20 years in the field, Reveal 3.3 offers a number of key ease-of-use and productivity enhancements, including:
- Study budget interface, enabling faster review of budgeted payables.
- A “Next Appointment” feature, which provides at-a-glance patient information, helping coordinators prepare for upcoming appointments.
- A capability allowing users to project and review patient visit “windows," helping to improve protocol compliance.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
